Henry Schein, Inc. – NASDAQ:HSIC
Henry Schein stock price today
$68.31
-2.10
-3%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
Henry Schein stock price monthly change
+8.09%
month
Henry Schein stock price quarterly change
+8.09%
quarter
Henry Schein stock price yearly change
-7.15%
year
Henry Schein key metrics
Market Cap | 8.79B |
Enterprise value | 12.93B |
P/E | 21.57 |
EV/Sales | 1.02 |
EV/EBITDA | 13.41 |
Price/Sales | 0.91 |
Price/Book | 3.35 |
PEG ratio | -1.73 |
EPS | 2.98 |
Revenue | 12.45B |
EBITDA | 917M |
Income | 388M |
Revenue Q/Q | 3.66% |
Revenue Y/Y | -0.61% |
Profit margin | 4.25% |
Oper. margin | 6.94% |
Gross margin | 30.29% |
EBIT margin | 6.94% |
EBITDA margin | 7.36% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHenry Schein stock price history
Henry Schein stock forecast
Henry Schein financial statements
Average Price Target
$70.5
Potential upside: 3.20%
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 3.1B | 140M | 4.52% |
|---|---|---|---|
| Sep 2023 | 3.16B | 137M | 4.33% |
| Dec 2023 | 3.01B | 18M | 0.6% |
| Mar 2024 | 3.17B | 93M | 2.93% |
| Jul 2023 | 9146000000 | 4.14B | 45.27% |
|---|---|---|---|
| Sep 2023 | 9810000000 | 4.70B | 48% |
| Dec 2023 | 10573000000 | 5.42B | 51.26% |
| Mar 2024 | 10145000000 | 5.11B | 50.37% |
| Jul 2023 | 274M | -301M | 38M |
|---|---|---|---|
| Sep 2023 | 231M | -468M | 248M |
| Dec 2023 | -32M | -327M | 394M |
| Mar 2024 | 197M | -166M | -57M |
Henry Schein alternative data
| Sep 2023 | 23,000 |
|---|---|
| Oct 2023 | 23,000 |
| Nov 2023 | 23,000 |
| Dec 2023 | 24,000 |
| Jan 2024 | 24,000 |
| Feb 2024 | 24,000 |
| Mar 2024 | 25,000 |
| Apr 2024 | 25,000 |
| May 2024 | 25,000 |
| Jun 2024 | 25,000 |
| Jul 2024 | 25,000 |
Henry Schein other data
92.43%
+0.59%
of HSIC is owned by hedge funds
571
+26
128.69M
-1.50M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 68124 |
| Mar 2024 | 0 | 18104 |
| Jun 2024 | 0 | 4134 |
| Aug 2024 | 0 | 3000 |
| Sep 2024 | 0 | 21035 |
| Nov 2024 | 0 | 12240 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | ETTINGER MICHAEL S officer: EVP & Chief Operating .. | Common Stock, par value $0.01 per share | 12,240 | $75 | $918,000 | ||
Sale | MCGLYNN LORELEI officer: SVP, Chief Human Res. .. | Common Stock, par value $0.01 per share | 21,035 | $69.3 | $1,457,726 | ||
Sale | MLOTEK MARK E director, officer.. | Common Stock, par value $0.01 per share | 3,000 | $69.12 | $207,360 | ||
Sale | MLOTEK MARK E director, officer.. | Common Stock, par value $0.01 per share | 3,000 | $69.12 | $207,360 | ||
Sale | SIEGEL WALTER officer: Sr. VP &.. | Common Stock, par value $0.01 per share | 4,134 | $69.47 | $287,189 | ||
Sale | CONNETT BRADFORD C officer: CEO, NA Distribution G.. | Common Stock, par value $0.01 per share | 6,430 | $74.28 | $477,620 | ||
Sale | BRESLAWSKI JAMES P director, officer.. | Common Stock, par value $0.01 per share | 2,907 | $74.37 | $216,194 | ||
Sale | BRESLAWSKI JAMES P director, officer.. | Common Stock, par value $0.01 per share | 2,907 | $74.37 | $216,194 | ||
Sale | LASKAWY PHILIP A director | Common Stock, par value $0.01 per share | 4,278 | $76.29 | $326,369 | ||
Sale | BRESLAWSKI JAMES P director, officer.. | Common Stock, par value $0.01 per share | 2,907 | $76.5 | $222,386 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 13 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
Henry Schein: Still Bullish Even As Shares Languish
Lantheus Holdings: A Growing Business With Dominant Market Share
Henry Schein: Economic Value Matches Market-Implied Expectations, Reiterate Hold
Henry Schein: Starting To Look Appealing Again
Henry Schein: Competitive Positioning Makes It A Compelling Buy
Patterson Companies: A Prospect To Brighten Your Smile
Henry Schein: Resiliency Premium Still In Situ
Henry Schein: Long-Term Value Selling Cheap, But Could Get More Attractive
Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios
-
What's the price of Henry Schein stock today?
One share of Henry Schein stock can currently be purchased for approximately $68.31.
-
When is Henry Schein's next earnings date?
Unfortunately, Henry Schein's (HSIC) next earnings date is currently unknown.
-
Does Henry Schein pay dividends?
No, Henry Schein does not pay dividends.
-
How much money does Henry Schein make?
Henry Schein has a market capitalization of 8.79B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.44% to 12.34B US dollars.
-
What is Henry Schein's stock symbol?
Henry Schein, Inc. is traded on the NASDAQ under the ticker symbol "HSIC".
-
What is Henry Schein's primary industry?
Company operates in the Healthcare sector and Medical - Distribution industry.
-
How do i buy shares of Henry Schein?
Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Henry Schein's key executives?
Henry Schein's management team includes the following people:
- Mr. Stanley M. Bergman Executive Chairman & Chief Executive Officer(age: 75, pay: $4,350,000)
- Mr. James P. Breslawski Executive Vice Chairman & Pres(age: 71, pay: $1,880,000)
- Mr. Gerald A. Benjamin Executive Vice President, Chief Admin. Officer & Executive Director(age: 72, pay: $1,560,000)
- Mr. Steven Paladino Executive Vice President, Chief Financial Officer & Executive Director(age: 68, pay: $1,510,000)
- Mr. Mark E. Mlotek Executive Vice President, Chief Strategic Officer & Executive Director(age: 69, pay: $1,480,000)
-
How many employees does Henry Schein have?
As Jul 2024, Henry Schein employs 25,000 workers.
-
When Henry Schein went public?
Henry Schein, Inc. is publicly traded company for more then 29 years since IPO on 3 Nov 1995.
-
What is Henry Schein's official website?
The official website for Henry Schein is henryschein.com.
-
Where are Henry Schein's headquarters?
Henry Schein is headquartered at 135 Duryea Road, Melville, NY.
-
How can i contact Henry Schein?
Henry Schein's mailing address is 135 Duryea Road, Melville, NY and company can be reached via phone at +63 18435500.
-
What is Henry Schein stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Henry Schein in the last 12 months, the avarage price target is $70.5. The average price target represents a 3.20% change from the last price of $68.31.
Henry Schein company profile:
Henry Schein, Inc.
henryschein.comExchange:
NASDAQ
Full time employees:
26,000
Industry:
Medical - Distribution
Sector:
Healthcare
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
135 Duryea Road
Melville, NY 11747
Melville, NY 11747
CIK: 0001000228
ISIN: US8064071025
CUSIP: 806407102
